Are hazelnuts good for fatty liver? Many people with non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD) seek dietary strategies to support liver health. Hazelnuts, rich in monounsaturated fats, vitamin E, and antioxidants, may offer benefits when included as part of a Mediterranean-style eating pattern. Whilst no studies have tested hazelnuts alone for fatty liver outcomes, research on nuts generally suggests they support metabolic health and may help reduce liver fat when consumed in appropriate portions. This article examines the evidence for hazelnuts in fatty liver disease management, their nutritional profile, and how to incorporate them safely into a liver-friendly diet alongside broader lifestyle modifications recommended by NICE guidance.

Understanding Fatty Liver Disease and Dietary Management

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells. The condition exists in two primary forms: non-alcoholic fatty liver disease (NAFLD), which affects individuals who drink little to no alcohol, and alcohol-related liver disease (ARLD), caused by excessive alcohol consumption. You may also encounter the newer terms metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), which are increasingly used in UK services. NAFLD/MASLD has become increasingly prevalent in the UK, affecting approximately one in three adults, often associated with obesity, type 2 diabetes, and metabolic syndrome.

The liver plays a crucial role in metabolising nutrients, filtering toxins, and regulating blood sugar levels. Steatosis is defined as fat accumulation in 5% or more of liver cells (hepatocytes) or elevated liver fat on imaging. When left unmanaged, simple steatosis can progress to non-alcoholic steatohepatitis (NASH/MASH), characterised by inflammation and potential scarring. Over time, this may advance to cirrhosis or liver failure. Many individuals with fatty liver disease experience no symptoms initially, though some report fatigue, discomfort in the upper right abdomen, or general malaise.

Dietary management forms the cornerstone of treatment for fatty liver disease, particularly NAFLD. NICE guidance (NG49) emphasises lifestyle modification as the primary intervention, focusing on gradual weight loss (7–10% of body weight), increased physical activity (at least 150 minutes of moderate-intensity exercise weekly), and dietary improvements. Mediterranean-style dietary patterns have demonstrated particular promise in research, characterised by high consumption of vegetables, fruits, whole grains, legumes, nuts, and olive oil, with moderate fish intake and limited red meat and processed foods. NICE recommends Mediterranean-style diets in the context of type 2 diabetes and cardiovascular disease prevention, and these principles align well with fatty liver disease management.

NICE NG49 recommends risk stratification in primary care using the FIB-4 score to identify patients who may have advanced fibrosis. For adults under 65 years, a FIB-4 score below 1.3 indicates low risk, whilst a score above 2.67 indicates higher risk. For those aged 65 and over, the thresholds are below 2.0 (low risk) and above 2.67 (higher risk). Patients with indeterminate or high scores may require a second-line Enhanced Liver Fibrosis (ELF) blood test and possible referral to a specialist hepatology service. Understanding which specific foods support liver health has become an important area of research. Nuts, including hazelnuts, have attracted scientific interest due to their unique nutritional composition and potential hepatoprotective properties. However, dietary recommendations must be individualised, considering each patient's overall health status, comorbidities, and nutritional requirements.

Nutritional Profile of Hazelnuts and Liver Health

Hazelnuts (Corylus avellana) possess a distinctive nutritional profile that may offer benefits for individuals with fatty liver disease. A 30g serving (approximately 20 hazelnuts) provides around 180 calories, predominantly from healthy monounsaturated fats, particularly oleic acid. Monounsaturated fatty acids, including oleic acid, typically comprise 70–80% of the fatty acids in hazelnuts. This fatty acid profile resembles that of olive oil, a cornerstone of Mediterranean-style eating patterns associated with improved metabolic health.

Beyond their favourable fat composition, hazelnuts are rich in vitamin E (alpha-tocopherol), providing approximately 4–5mg per 30g serving. Vitamin E functions as a potent antioxidant, protecting cell membranes from oxidative damage—a key mechanism in the progression of fatty liver disease to NASH. The nuts also contain significant amounts of B vitamins (particularly folate and B6), magnesium, copper, and manganese, all of which support various metabolic processes relevant to liver function.

Hazelnuts provide approximately 3g of dietary fibre per 30g serving, contributing to improved glycaemic control and gut health. Emerging research suggests that gut microbiome composition may influence liver health through the gut-liver axis, with fibre playing a modulatory role, though this area requires further investigation. The nuts also contain phytosterols and polyphenolic compounds, including proanthocyanidins and flavonoids, which possess anti-inflammatory and antioxidant properties.

The protein content of hazelnuts (approximately 4g per 30g) includes arginine, an amino acid involved in nitric oxide production and vascular health. Importantly, hazelnuts have a low carbohydrate load and minimal impact on postprandial (after-meal) blood glucose, making them suitable for individuals with insulin resistance—a common feature of NAFLD. Their nutrient density and satiating properties may also support weight management efforts, crucial for fatty liver disease management. Nutritional composition data are available from the UK Nutrient Databank (McCance and Widdowson's Composition of Foods) and similar authoritative sources.

Are Hazelnuts Good for Fatty Liver? The Evidence

The scientific evidence regarding hazelnuts specifically for fatty liver disease remains limited. No randomised controlled trials have tested hazelnuts alone for NAFLD outcomes; however, research on nuts generally and the mechanisms of their constituent nutrients suggest potential benefits when included as part of a healthy dietary pattern. It is important to emphasise that hazelnuts are not a treatment or cure for fatty liver disease, but may form part of a liver-supportive diet.

Studies examining nut consumption broadly have shown promising associations. Systematic reviews and meta-analyses, including those published in the journal Nutrients, have found that regular nut consumption is associated with reduced risk of NAFLD and improved liver enzyme profiles in observational studies. The PREDIMED study (published in the New England Journal of Medicine, 2013), a landmark Mediterranean diet trial, demonstrated that participants consuming nuts regularly (including hazelnuts, walnuts, and almonds as a daily 30g supplement) showed improvements in metabolic parameters associated with liver health, including reduced waist circumference, improved insulin sensitivity, and decreased inflammatory markers. It is important to note that liver outcomes were not primary endpoints in PREDIMED, so these findings are indirect.

The antioxidant capacity of hazelnuts, particularly their vitamin E content, may help mitigate oxidative stress—a key driver of hepatic inflammation and fibrosis progression. Research, including the PIVENS trial (New England Journal of Medicine), indicates that high-dose vitamin E supplementation (800 IU daily, far exceeding dietary intake) can improve liver histology in some adults with NASH, though this remains an area of ongoing investigation. NICE NG49 notes that vitamin E may be considered by specialists in selected patients with biopsy-proven NASH. Patients should not self-supplement with high-dose vitamin E; any use should be under specialist advice. Dietary vitamin E from hazelnuts is much lower and considered safe.

Monounsaturated fats, abundant in hazelnuts, have been associated with improved liver fat content in intervention studies. Research published in the European Journal of Nutrition and similar journals has found that replacing saturated fats with monounsaturated fats can improve markers of hepatic steatosis. However, it is important to emphasise that hazelnuts should be viewed as one component of an overall healthy dietary pattern rather than a singular therapeutic intervention. Portion control remains essential, as nuts are energy-dense, and excessive calorie intake—regardless of source—can worsen fatty liver disease. Current evidence and guidance from the British Heart Foundation and British Dietetic Association suggest that 30g daily as part of a balanced, calorie-controlled diet represents a reasonable approach for most people.

How to Include Hazelnuts in a Liver-Friendly Diet

Incorporating hazelnuts into a liver-friendly diet requires thoughtful planning to maximise benefits whilst managing calorie intake. A recommended portion size is 30g daily (approximately a small handful or 20 whole hazelnuts), which provides nutritional benefits without excessive calories. This quantity aligns with general guidance for nut consumption in healthy eating patterns, including the NHS Eatwell Guide, and can be adapted based on individual energy requirements and weight management goals.

Practical ways to include hazelnuts in your diet include adding chopped hazelnuts to porridge or unsweetened yoghurt at breakfast, providing sustained energy and satiety. They can be lightly toasted and sprinkled over salads, adding texture and flavour whilst increasing the nutritional value of vegetable-rich meals. Ground hazelnuts can be incorporated into wholegrain baking or used as a coating for fish or chicken, offering a nutrient-dense alternative to breadcrumbs. Some individuals enjoy hazelnut butter (without added sugar or palm oil) spread thinly on wholegrain toast or added to smoothies.

When selecting hazelnuts, choose raw or dry-roasted varieties without added salt, sugar, or oils. Avoid chocolate-coated or honey-roasted options, as these contain added sugars and calories that may worsen metabolic health. Store hazelnuts in an airtight container in a cool, dark place or refrigerate to prevent rancidity, as their high fat content makes them susceptible to oxidation.

Important considerations include accounting for the calories from hazelnuts within your overall daily intake, particularly if weight loss is a therapeutic goal. If you have difficulty with portion control, pre-portion nuts into 30g servings. Individuals with nut allergies should obviously avoid hazelnuts and check food labels carefully for 'may contain nuts' warnings and cross-contamination risks; seek alternative sources of healthy fats, such as olive oil, avocados, or seeds. Those taking anticoagulant medications (such as warfarin) should seek advice from their GP or pharmacist before starting high-dose vitamin E supplements, as very high amounts may theoretically affect clotting. Dietary amounts of vitamin E from hazelnuts are generally safe and unlikely to pose concerns, but discuss any questions with your healthcare team.

If you experience a suspected side effect from any medicine or supplement mentioned in this article (including anticoagulants or vitamin E supplements), you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Other Dietary Considerations for Fatty Liver Disease

Whilst hazelnuts may contribute to a liver-supportive diet, comprehensive dietary management of fatty liver disease requires a broader approach. Mediterranean-style dietary patterns are supported by research and align with NICE guidance for related conditions such as type 2 diabetes and cardiovascular disease. These patterns emphasise whole foods, plant-based ingredients, and healthy fats whilst limiting processed foods, refined carbohydrates, and added sugars. The European Association for the Study of the Liver (EASL) and British Society of Gastroenterology (BSG) also support Mediterranean-style eating for metabolic liver disease.

Key dietary principles include increasing consumption of vegetables and fruits (aiming for at least five portions daily), choosing wholegrain carbohydrates over refined alternatives, and incorporating oily fish (such as salmon, mackerel, or sardines) twice weekly for omega-3 fatty acids. Lean protein sources, including poultry, legumes, and plant-based proteins, should replace processed and red meats. Extra virgin olive oil should be the primary cooking and dressing fat, whilst saturated fats from butter, cream, and fatty meats should be minimised.

Foods and beverages to limit or avoid include sugar-sweetened drinks, fruit juices, and foods high in added sugars, as fructose metabolism in the liver can exacerbate fat accumulation. Alcohol guidance aligns with UK Chief Medical Officers' recommendations: to keep health risks low, do not regularly drink more than 14 units per week, and spread drinking over three or more days if you do drink this amount. Avoid binge drinking. If you have advanced liver disease or NASH, your specialist may advise complete abstinence; seek personalised advice. Ultra-processed foods, high in refined carbohydrates, unhealthy fats, and additives, should be replaced with minimally processed alternatives. Avoid products listing partially hydrogenated oils, though industrial trans fats have been largely eliminated from the UK food supply.

Practical lifestyle measures include eating regular meals to maintain stable blood sugar levels, staying well-hydrated with water as the primary beverage, and combining dietary changes with regular physical activity (at least 150 minutes of moderate-intensity exercise weekly, as per UK Chief Medical Officers' guidelines). Gradual, sustainable weight loss of 0.5–1kg per week is preferable to rapid weight reduction. NICE NG49 recommends monitoring low-risk patients in primary care with repeat FIB-4 testing and lifestyle review; intervals depend on individual risk factors. Patients with indeterminate or high FIB-4 scores, or elevated ELF tests, should be referred to specialist hepatology services for further assessment.

Contact your GP if you experience persistent abdominal pain, unexplained weight loss, or significant fatigue. Seek urgent medical assessment (same-day GP appointment, NHS 111, or attend A&E) if you develop jaundice (yellowing of skin or eyes), confusion, vomiting blood or coffee-ground material, black tarry stools, dark urine with pale stools, or new abdominal swelling (ascites), as these may indicate disease progression or complications requiring immediate medical attention. Regular monitoring through blood tests and, when indicated, imaging or specialist referral ensures appropriate disease management and early detection of complications. Further information and support are available from the NHS, British Liver Trust, and your local healthcare team.

Frequently Asked Questions